Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 6/20 | 0.45 |
| ▸ | DRD3 | P35462 | 5/20 | 0.45 |
| ▸ | DRD4 | P21917 | 3/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5773122 | 0.89 | MAPT (0.42) | SIGMAR1DRD4HTR1AHTR7POLB | |
| SCHEMBL5775621 | 0.89 | SIGMAR1 (0.48) | SIGMAR1DRD2DRD3DRD4HTR1A | |
| SCHEMBL5772376 | 0.89 | HTR1A (0.43) | SIGMAR1DRD2DRD3DRD4PARP1 | |
| SCHEMBL5776684 | 0.84 | SIGMAR1 (0.53) | SIGMAR1KCNH2DRD2DRD3DRD4 | |
| SCHEMBL5772832 | 0.84 | SIGMAR1 (0.53) | SIGMAR1KCNH2DRD2DRD3DRD4 | |
| SCHEMBL5772457 | 0.83 | SIGMAR1 (0.52) | SIGMAR1KCNH2DRD2DRD3DRD4 | |
| SCHEMBL8563596 | 0.82 | KCNH2 (0.44) | SIGMAR1KCNH2DRD2DRD3DRD4 | |
| SCHEMBL8563591 | 0.80 | SIGMAR1 (0.49) | SIGMAR1KCNH2DRD2DRD3DRD4 | |
| Fumaric Acid SCHEMBL5773660 | 0.77 | DRD2 (0.45) | SIGMAR1KCNH2DRD2DRD3DRD4 | |
| Maleic Acid SCHEMBL5773645 | 0.77 | DRD2 (0.45) | SIGMAR1KCNH2DRD2DRD3DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0885883-B1 | FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF | MITSUBISHI PHARMA CORP (JP) | 2006-11-02 | — | — | EP | disclosed |
| US-6187774-B1 | N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2001-02-13 | — | — | US | disclosed |
| EP-0885883-A1 | FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1998-12-23 | — | — | EP | disclosed |